Sustained suppression of xenoreactive natural antibodies: anti-IgM monoclonal antibody and anti-B cell immunosuppressants.
Van der Werf
W J
WJ
Sandoz Center for Immunobiology, Harvard Medical School, Boston, Massachusetts.
Blakely
M L
ML
Hancock
W
W
Soares
M
M
Latinne
D
D
Bazin
H
H
Bach
F H
FH
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis* / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016572:Cyclosporine / Q000494:pharmacology; D017707:Erythrocyte Transfusion; D006168:Guinea Pigs; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D010956:Plasmapheresis; D011090:Polyenes / Q000494:pharmacology; D051381:Rats; D011917:Rats, Inbred Lew; D020123:Sirolimus; D013156:Splenectomy
D000910:Antibodies, Heterophile; D000911:Antibodies, Monoclonal; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D020123:Sirolimus